DCC has bought British generic drugs company Kent Pharmaceuticals in a move that will significantly increase the scale of the company’s pharma business, it said.
The deal is based on an enterprise valuation of €71.2 million and is subject to approval from the Irish Competition Authority. DCC anticipates that the transaction will be completed by its healthcare division in early 2013.
Kent is involved in the development, manufacture, sales, marketing and distribution of generic...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team